Hypoimmunogenic Human iPSCs for Repair and Regeneration in the CNS
Cells · 2025
DOI: 10.3390/cells14161248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Haiwei Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Science, Florida International University, 11350 SW Village Pkwy, Port St. Lucie, FL 34987, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Central Nervous System, Regeneration. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, DoD.
Abstract (Originalsprache)
Human induced pluripotent stem cells (iPSCs) can be genetically engineered to evade host immune recognition, rendering them hypoimmunogenic and suitable as “universal donor” cells for allogeneic transplantation. Such modifications enable the development of off-the-shelf iPSC-derived therapeutics that are immediately available for clinical use without the need for patient-specific derivation or immunosuppression. This review focuses on recent developments in strategies for generating hypoimmunogenic human iPSCs, with particular emphasis on their applications in central nervous system (CNS) cell therapy and repair. We assess immunomodulatory factors based on their immune functions and potential roles in CNS development and disease, with the goal of identifying strategies to use these factors either individually, in combination, or alongside gene editing to reduce immune rejection without compromising neurogenesis or tissue repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Translational Science, Florida International University, 11350 SW Village Pkwy, Port St. Lucie, FL 34987, USA.
- Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL 33199, USA.
- Biomedical Science PhD Program, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
ORCID-Profile: Haiwei Zhang, Qilin Cao, Ying Liu
Förderung
- NINDS NIH HHS
- NIH HHS
- DoD
- Craig H. Neilsen
- Wellcome Trust
- FIU start-up funds
- NIH
Zitieren
APA
Zhang, H., Zhou, H., Xia, X., Cao, Q., & Liu, Y. (2025). Hypoimmunogenic Human iPSCs for Repair and Regeneration in the CNS. Cells. https://doi.org/10.3390/cells14161248
Vancouver
Zhang H, Zhou H, Xia X, Cao Q, Liu Y. Hypoimmunogenic Human iPSCs for Repair and Regeneration in the CNS. Cells. 2025. doi:10.3390/cells14161248
BibTeX
@article{Zhang2025,
author = {Zhang, Haiwei and Zhou, Hongxia and Xia, Xugang and Cao, Qilin and Liu, Ying},
title = {Hypoimmunogenic Human iPSCs for Repair and Regeneration in the CNS},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14161248}
}
EUVIMED